BMS-1166 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as an inhibitor targeting specific pathways involved in tumor growth and survival. Researchers employ BMS-1166 to investigate its potential in disrupting cancer cell proliferation and enhancing the efficacy of existing treatments. Its application extends to preclinical studies, where it is used to evaluate its impact on various cancer models, providing insights into its mechanism of action and therapeutic potential. Additionally, BMS-1166 is explored for its role in combination therapies, aiming to improve outcomes in challenging cancer cases. Its use contributes significantly to advancing understanding in oncology and developing innovative treatment strategies.